Risk factors for ocular toxoplasmosis among uveitis patients in Kinshasa, DR CongoNadine Nsiangani Lusambo, Dieudonné Kaimbo Wa Kaimbo, Dieudonné Mumba Ngoyi, Pierre Akilimali Zalagile, Alejandra de-la-Torre
20 January 2023
Colombian ocular inflammatory diseases epidemiology study (COIDES): prevalence, incidence and sociodemographic characterisation of Scleritis in Colombia, 2015–2020Carlos Cifuentes-González, William Rojas-Carabali, Germán Mejia-Salgado, Juan Sebastián Pineda-Sierra, Paula Tatiana Muñoz-Vargas, Laura Boada-Robayo, Danna Lesley Cruz, Alejandra de-la-Torre
14 November 2022
Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer’s perspectiveSeenu M Hariprasad, George Joseph, Patrick Gagnon-Sanschagrin, Elizabeth Serra, Subrata Bhattacharyya, Jérôme Bédard, Annie Guérin, Thomas Arno Albini
10 November 2021
Adalimumab in patients with vision-threatening uveitis: real-world clinical experienceTimothy Lee Tang Lee Say, Verlyn Yang, Jacob M Fingret, Sophia Zagora, Richard Symes, Christine Younan, Elisa Eleanor Cornish, Nitin Verma, Anthony Sammel, Denis Wakefield, Deborah Speden, Peter J McCluskey
27 September 2021